Followers | 375 |
Posts | 16984 |
Boards Moderated | 4 |
Alias Born | 03/07/2014 |
![](https://investorshub.advfn.com/uicon/458287.png?cb=1657037051)
Friday, January 30, 2015 10:36:51 AM
You think this company is suddenly worth twice what it was when the toxic debt financing folks just buried it to sub 1 cent only a week or two ago? Really?
Hey, sounds good to me. It'll be going right back down when the dilution shares are sold- this is nothing new. Seen this how many times on this one? It's like a broken record. Vast PR hype claims after it hits a near all time low- it suddenly lights up every penny board there is? They even had to disclose paid penny promotion in several past instances.
What, the company is suddenly worth more today? Based on what? How much does one think they just tapped Magna for, for survival cash? How much? What's changed in a month about their desperate financial position?
What are they going to suddenly fund all these grand "plans" with- when those trials have sat parked for going on FIVE YEARS now for "lack of funding" and their own $800K "bonuses" just got paid via a "promissory note" cause they have no cash (see SEC 10-Q, latest)- what's gonna pay for this now?
Explain where MIRROR went? What happened? It was never "FULLY FUNDED BY BIOHEART" as the vast "PR" claimed- we just learned in that PR yesterday, Jan 25th, 2015 that for all intents and purposes, after 1.5 yrs of "talking it up" that MIRROR, the big phase 3 trial NEVER EVEN HAPPENED, it DID NOT OCCUR and was NEVER FUNDED, not by Bioheart or any one else.
If that original MIRROR PR and hype campaign and all those vast claims about made originally, versus what really we really now know occurred- if that isn't "troubling" then I don't know what is, IMO.
http://www.marketwired.com/press-release/bioheart-announces-phase-iii-mirror-trial-for-myocell-initiated-otcqb-bhrt-1807938.htm
Then latest filed 10-Q, PAGE 29:
" We have initiated and enrolled our first patient in the MIRROR trial in 2013. The trial is very similar to the MARVEL trial but focusses on sites outside the US. We will continue enrollment in the MIRROR trial once we have secured sufficient funds."
Then, REALITY from yesterday's ole "PR", Jan 25th, 2015:
"The Company has no further plans to advance its ANGEL and MIRROR clinical development programs."
Yeah, nothing wrong with that picture, Noooo. Sure. Just vanished- an entire supposed phase 3 trial, that it turns out- just NEVER WAS and NEVER HAPPENED. Right on.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM